Acuta Capital Partners as of Dec. 31, 2016
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 45 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Veracyte (VCYT) | 11.2 | $30M | 3.9M | 7.74 | |
| Lion Biotechnologies | 10.2 | $28M | 4.0M | 6.95 | |
| IRIDEX Corporation (IRIX) | 8.1 | $22M | 1.6M | 14.06 | |
| Immunomedics | 6.5 | $18M | 4.8M | 3.67 | |
| Neuroderm Ltd F | 5.5 | $15M | 666k | 22.20 | |
| Edge Therapeutics | 4.8 | $13M | 1.0M | 12.50 | |
| Assembly Biosciences | 4.5 | $12M | 987k | 12.15 | |
| Ascendis Pharma A S (ASND) | 4.3 | $12M | 575k | 20.24 | |
| Immunomedics Inc note 4.750% 2/1 | 3.9 | $10M | 11M | 0.99 | |
| Aclaris Therapeutics (ACRS) | 3.8 | $10M | 373k | 27.14 | |
| iShares Russell 2000 Index (IWM) | 3.5 | $9.4M | 70k | 134.86 | |
| ACADIA Pharmaceuticals (ACAD) | 3.2 | $8.7M | 300k | 28.84 | |
| Chembio Diagnostics | 2.9 | $7.8M | 1.2M | 6.80 | |
| Akebia Therapeutics (AKBA) | 2.7 | $7.3M | 699k | 10.41 | |
| Oxford Immunotec Global | 2.6 | $7.0M | 471k | 14.95 | |
| Marvell Technology Group | 2.6 | $6.9M | 500k | 13.87 | |
| CAS Medical Systems | 2.5 | $6.7M | 4.2M | 1.61 | |
| Ra Pharmaceuticals | 2.1 | $5.7M | 378k | 15.19 | |
| Gw Pharmaceuticals Plc ads | 1.7 | $4.5M | 40k | 111.75 | |
| Nabriva Therapeutics | 1.6 | $4.2M | 706k | 5.96 | |
| WebMD Health | 1.5 | $4.0M | 80k | 49.58 | |
| Dbv Technologies S A (DBVT) | 1.2 | $3.2M | 92k | 35.13 | |
| Dermira | 1.0 | $2.7M | 89k | 30.33 | |
| Vanda Pharmaceuticals (VNDA) | 1.0 | $2.6M | 163k | 15.95 | |
| Recro Pharma (SCTL) | 0.9 | $2.4M | 300k | 8.06 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $2.1M | 1.0M | 2.10 | |
| Aerie Pharmaceuticals | 0.7 | $1.9M | 50k | 37.86 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $1.6M | 249k | 6.33 | |
| Zimmer Holdings (ZBH) | 0.6 | $1.5M | 15k | 103.20 | |
| Clearside Biomedical (CLSD) | 0.6 | $1.6M | 175k | 8.94 | |
| Sarepta Therapeutics (SRPT) | 0.5 | $1.4M | 50k | 27.44 | |
| Essa Pharma | 0.5 | $1.3M | 605k | 2.20 | |
| Exelixis (EXEL) | 0.4 | $1.2M | 80k | 14.91 | |
| Alimera Sciences | 0.4 | $1.1M | 974k | 1.08 | |
| Rockwell Medical Technologies | 0.3 | $917k | 140k | 6.55 | |
| Amicus Therapeutics (FOLD) | 0.3 | $722k | 145k | 4.97 | |
| Spectranetics Corporation | 0.2 | $674k | 28k | 24.51 | |
| Ardelyx (ARDX) | 0.1 | $382k | 27k | 14.21 | |
| Endologix Inc note 2.250%12/1 | 0.0 | $86k | 96k | 0.90 | |
| Oncobiologics | 0.0 | $88k | 29k | 3.03 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $76k | 97k | 0.78 | |
| MannKind Corporation | 0.0 | $58k | 90k | 0.64 | |
| Pluristem Therapeutics | 0.0 | $30k | 21k | 1.42 | |
| Ohr Pharmaceutical | 0.0 | $15k | 10k | 1.50 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $18k | 97k | 0.19 |
